State Rep. Park Cannon and Dr. David Holland

Queer Georgia state representative pushes PrEP bill

Georgia could launch a three-year statewide pilot program to distribute free pre-exposure HIV prophylaxis — or PrEP — to men and women at high risk for infection before 2021, under legislation working its way t...
Ask The Doctor

Ask The Doctor: Should I take PrEP?

Q: I'm a 27-year-old gay man and I'm considering whether to take PrEP or not. What factors should I consider in making my decision? And isn't it pricey? A: Anyone who wants to minimize their risk of getting ...

5 LGBT things you need to know today, June 23

1. The Mississippi governor signed House Bill 1523 a year ago, and this week the Fifth Circuit Court of Appeals made the so-called "religious freedom" bill law. Advocates are calling it "the worst anti-LGBT law...
article placeholder

Don’t discount anti-HIV drugs as prevention tool for gay men

To the Editor:

A robust discussion is underway about the potential use of anti-HIV drugs to prevent HIV infection (also known as pre-exposure prophylaxis or PrEP).  Our study, called iPrEx, provided the first evidence that the daily use of PrEP with the FDA-approved HIV treatment Truvada can significantly reduce HIV infection risk in gay, bisexual and other men who have sex with men (MSM) and transgender women.

Recently, a private healthcare provider began a paid advertising campaign urging the FDA not to even consider approving PrEP — charging that MSM will stop using condoms if PrEP is permitted.

The pros and cons of PrEP use should be vigorously debated — but that debate should be based on facts, rather than the assumption that MSM will not act to protect themselves and others from infection. Here are the facts about the iPrEX study: